Xolair (omalizumab) - Roche, Novartis
Tezspire (tezepelumab-ekko) - AstraZeneca, Amgen
Nucala (mepolizumab) - GSK
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/42798376
 
Baozhu Huang; Chunjie Tian; Danxian Jiang; Feng Li; Huikuan Chen; Junfeng Hao; Ting Liu; Weibang Chen; Wenya Gao; Xiaoman Li; Xiaoyu Gao; Xiaoyu Liu; Xue Wang; Ye Tian; Yue Xu; Yurong Zhang
 
Sep 27, 2026
 
Prev Next